Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.
about
Use of Animal Models in Understanding Cancer-induced Bone PainPrognostic value of magnetic resonance imaging-detected cranial nerve invasion in nasopharyngeal carcinomaDissociation between the relief of skeletal pain behaviors and skin hypersensitivity in a model of bone cancer pain.Mechanisms of nerve growth factor signaling in bone nociceptors and in an animal model of inflammatory bone pain.The neurobiology of cancer pain.The neurobiology of skeletal painNGF blockade at early times during bone cancer development attenuates bone destruction and increases limb useMechanisms of nerve capping technique in prevention of painful neuroma formationNeural regulation of hematopoiesis, inflammation, and cancer.NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling.Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancerLevo-Tetrahydropalmatine Attenuates Bone Cancer Pain by Inhibiting Microglial Cells ActivationAblation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer.The Adaptor Protein CD2AP Is a Coordinator of Neurotrophin Signaling-Mediated Axon Arbor Plasticity.Impacts of anti-nerve growth factor antibody on pain-related behaviors and expressions of opioid receptor in spinal dorsal horn and dorsal root ganglia of rats with cancer-induced bone pain.Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments.Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain.Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis.Oxidative stress and cancer pain.Cancer-induced bone pain: Mechanisms and models.Neurotrophins, endocannabinoids and thermo-transient receptor potential: a threesome in pain signalling.Pro-neurotrophins, sortilin, and nociception.New insights of nociceptor sensitization in bone cancer pain.Emerging factors in the progression of cancer-related pain.Anti-nerve growth factor therapy increases spontaneous day/night activity in mice with orthopedic surgery-induced pain.Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist in a rat model of prostate cancer-induced bone pain.Protease-activated receptor 2 in dorsal root ganglion contributes to peripheral sensitization of bone cancer pain.How Schwann cells facilitate cancer progression in nerves.Molecular Mechanisms That Contribute to Bone Marrow PainNGF - the TrkA to successful pain treatmentCancer around the brain.Cancer pain physiology.Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation.PD-L1 inhibits acute and chronic pain by suppressing nociceptive neuron activity via PD-1.Gelatin-albumin hybrid nanoparticles as matrix metalloproteinases-degradable delivery systems for breast cancer therapy.Bone hyperalgesia after mechanical impact stimulation: a human experimental pain model.Functional effects of TrkA inhibition on system xC--mediated glutamate release and cancer-induced bone pain.
P2860
Q26785501-F998242B-0275-4103-8AFF-67DE175C7364Q30416507-896E7EB0-DA37-49A6-B9A3-83EE83E26A5CQ30831131-E30759B6-164E-4FF3-BF96-AA88CCB7729FQ33610520-E9EB91F7-9E6E-4B22-B924-2A9384243ABBQ34167635-EA84FCE8-2BD3-47FD-B0F0-4832B976F9F9Q34402192-3B9962D4-2042-4B95-8F8C-7F5708B6C92EQ34617294-7907880A-CE91-4A2E-80FB-99BC8FA6D417Q35140363-EFF36832-32F1-42EA-BDD4-4721B61FC90FQ35560457-549F53A9-AE3C-4525-ABB0-6B24BEC4C87FQ35588883-A11691D1-5084-43B9-BDF2-85DF577B4DC6Q35985440-6C23472A-CF05-4262-8CA9-E6F486B58894Q36447060-1AD8D02D-3164-4F79-8868-100B8924D31EQ36710531-3D60B415-B0DE-418B-B55E-504B3757A3D0Q36792598-D05B77A2-31F4-48CD-AEE7-A588AB5223CDQ37114759-5D549F92-0766-489A-ACB2-29789A5C3F18Q37187646-7EFC817E-3001-4B7D-B0FC-BA30C3DA2AF1Q37413252-81550BAE-8ED6-4EE5-8770-FCAC91CB28CAQ38013959-903BAFA8-A875-48F3-8830-787BEA5E6184Q38078000-41440A34-7E4B-4786-8E64-CB1F39647E78Q38146274-5AF47A7C-0366-4A3D-BF20-75C22189E30CQ38185067-24DCDE13-CDE9-4F6A-A621-A009BB6D6DE0Q38185068-75FA6994-8433-4C03-9D4F-AEEBF21AB615Q38303224-B46184EA-E143-4776-9A47-20E140D854B8Q38826785-C125A671-BACD-4B73-B654-6D9E5DD429A8Q38903010-6A936D2B-A30E-4905-A132-C6E41591F14BQ39033886-8EC8D506-36FB-4229-ABD3-7B441BBBFEDEQ39119150-74990BEC-6214-4AC6-B112-E9B31D33CA68Q39384853-54FF6788-66B5-4A20-8FDA-449BB5E1452BQ41684342-41580F54-D91F-4300-BB33-F5CCFDEB4285Q42325445-EA62ADC3-8A43-447F-9800-66386821ED73Q43197810-F29954BE-B9DE-42D7-A248-632CCA436AB8Q43205303-E525B140-FE29-41B0-ABFD-15F186595F40Q45060476-F41A8CA6-4DB5-44BF-82CF-CD5A9E0422A1Q50988830-06DE9A77-1DF6-4ED6-891E-5D965C7325DBQ51036547-68D95AA8-5CB5-476E-A15D-6E6F47EE5955Q51139005-EFB6174E-E07F-4A3C-99AC-56617F8F25F9Q54109841-C670DBF4-F294-459D-BE38-EA1BA78F2DEB
P2860
Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Preventive or late administrat ...... ma formation, and cancer pain.
@ast
Preventive or late administrat ...... ma formation, and cancer pain.
@en
type
label
Preventive or late administrat ...... ma formation, and cancer pain.
@ast
Preventive or late administrat ...... ma formation, and cancer pain.
@en
prefLabel
Preventive or late administrat ...... ma formation, and cancer pain.
@ast
Preventive or late administrat ...... ma formation, and cancer pain.
@en
P2093
P2860
P1433
P1476
Preventive or late administrat ...... ma formation, and cancer pain.
@en
P2093
Gabriela Castañeda-Corral
Joseph R Ghilardi
Juan Miguel Jimenez-Andrade
Michael A Kuskowski
Patrick W Mantyh
P2860
P304
P356
10.1016/J.PAIN.2011.07.020
P407
P577
2011-09-09T00:00:00Z